Crescent Biopharma (CBIO)
13.59
+0.52 (3.98%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on Crescent Biopharma Inc (CBIO)
October 19, 2026 8:09 AM - StreetInsider
Crescent Biopharma (CBIO) Reiterated at Buy by Stifel on Comprehensive Pipeline Update
October 16, 2026 7:08 AM - StreetInsider
Crescent Biopharma expands CR-001 trial with chemo combos
October 15, 2026 4:15 PM - StreetInsider
Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bis
October 15, 2026 4:15 PM - StreetInsider
Crescent Biopharma Announces Grants of Inducement Awards
October 6, 2026 4:15 PM - StreetInsider
Crescent Biopharma (CBIO) Reiterated at Buy by Stifel
October 6, 2026 7:50 AM - StreetInsider
H.C. Wainwright Upgrades Crescent Biopharma Inc (CBIO) to Buy
October 6, 2026 6:11 AM - StreetInsider
FDA clears Crescent Biopharma IND for CR-002 solid tumor ADC
October 5, 2026 7:31 AM - StreetInsider
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
October 5, 2026 7:30 AM - StreetInsider
Crescent Biopharma Announces Grants of Inducement Awards
September 25, 2026 4:15 PM - StreetInsider
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: Lynch Ryan
September 18, 2026 4:03 PM - SEC Filing
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: Pinkas Jan
September 18, 2026 4:03 PM - SEC Filing
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: Im Ellie Eunkyung
September 18, 2026 4:03 PM - SEC Filing
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: Scalzo Richard William
September 18, 2026 4:03 PM - SEC Filing
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: Bispham Barbara Harlin
September 18, 2026 4:02 PM - SEC Filing
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: Brumm Joshua T
September 18, 2026 4:02 PM - SEC Filing
Form 4 CRESCENT BIOPHARMA, INC. For: Sep 16 Filed by: McNeill Jonathan
September 18, 2026 4:02 PM - SEC Filing
Form S-8 CRESCENT BIOPHARMA, INC.
September 18, 2026 12:00 PM - SEC Filing
Form 144 CRESCENT BIOPHARMA, INC. Filed by: Brumm Joshua T
September 17, 2026 4:33 PM - SEC Filing
Form 144 CRESCENT BIOPHARMA, INC. Filed by: McNeill Jonathan
September 17, 2026 4:33 PM - SEC Filing
Form 144 CRESCENT BIOPHARMA, INC. Filed by: McNeill Jonathan
September 16, 2026 3:09 PM - SEC Filing
Form 144 CRESCENT BIOPHARMA, INC. Filed by: Brumm Joshua T
September 16, 2026 3:09 PM - SEC Filing
Crescent Biopharma Announces Grants of Inducement Awards
September 9, 2026 4:15 PM - StreetInsider
Crescent Biopharma to Present at September Investor Conferences
September 3, 2026 7:30 AM - StreetInsider
TD Cowen Assumes Crescent Biopharma Inc (CBIO) at Buy
August 22, 2026 7:55 AM - StreetInsider
Form SCHEDULE 13G/A CRESCENT BIOPHARMA, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
August 14, 2026 6:14 AM - SEC Filing
Crescent Biopharma Announces Grants of Inducement Awards
August 3, 2026 7:30 AM - StreetInsider
Form EFFECT CRESCENT BIOPHARMA, INC.
August 3, 2026 6:08 AM - SEC Filing
H.C. Wainwright Reiterates Neutral Rating on Crescent Biopharma Inc (CBIO)
July 31, 2026 6:47 AM - StreetInsider
Form POS AM CRESCENT BIOPHARMA, INC.
July 30, 2026 9:37 AM - SEC Filing
Form 424B3 CRESCENT BIOPHARMA, INC.
July 30, 2026 9:35 AM - SEC Filing
Form 10-Q CRESCENT BIOPHARMA, INC. For: Jun 30
July 30, 2026 9:25 AM - SEC Filing
Form 8-K CRESCENT BIOPHARMA, INC. For: Jul 30
July 30, 2026 7:36 AM - SEC Filing
Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
July 30, 2026 7:35 AM - StreetInsider
Crescent Biopharma Announces Grants of Inducement Awards
July 23, 2026 4:15 PM - StreetInsider
Full Article List
